Building a framework for embryonic microenvironments and cancer stem cells

Stem Cell Reviews and Reports

Volumn 5, Issue 4, 2009, Pages 319-327

  Ruiz Vela, Antonio ^a   Aguilar Gallardo, Cristóbal ^a   Simón, Carlos ^a,b  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cancer stem cell; Embryonic stem cells; Microenvironment; Niches; Reprogramming

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; HUMAN; METABOLISM; NEOPLASM;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 74649085850     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-009-9096-7     Document Type: Article

References (73)

1. Fuchs, E., Tumbar, T., & Guasch, G. (2004). Socializing with the neighbors: stem cells and their niche. Cell, 116(6), 769-778.
2. Morrison, S. J., & Spradling, A. C. (2008). Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell, 132(4), 598-611.
3. Rideout, W. M., 3rd, Hochedlinger, K., Kyba, M., Daley, G. Q., & Jaenisch, R. (2002). Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell, 109(1), 17-27.
4. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448(7151), 318-324.
5. Aleckovic, M., & Simón, C. (2008). Is teratoma formation in stem cell research a characterization tool or a window to developmental biology? Reproductive Biomedicine Online, 17(2), 270-280.
6. Hanna, J., Markoulaki, S., Mitalipova, M., Cheng, A. W., Cassady, J. P., Staerk, J., et al. (2009). Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell, 4(6), 513-524.
7. Blum, B., & Benvenisty, N. (2008). The tumorigenicity of human embryonic stem cells. Advances in Cancer Research, 100, 133-158.
8. Watt, F. M., & Hogan, B. L. (2000). Out of Eden: stem cells and their niches. Science, 287(5457), 1427-1430.
9. Morrison, S. J., & Spradling, A. C. (2008). Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell, 132(4), 598-611.
10. Oshima, H., Rochat, A., Kedzia, C., Kobayashi, K., & Barrandon, Y. (2001). Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell, 104(2), 233-245.
11. Taylor, G., Lehrer, M. S., Jensen, P. J., Sun, T. T., & Lavker, R. M. (2000). Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell, 102(4), 451-461.
12. Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W. E., Rendl, M., et al. (2004). Defining the epithelial stem cell niche in skin. Science, 303(5656), 359-363.
13. Chen, D., & McKearin, D. (2003). Dpp signaling silences bam transcription directly to establish asymmetric divisions of germline stem cells. Current Biology, 13(20), 1786-1791.
14. Zhao, G. Q., Deng, K., Labosky, P. A., Liaw, L., & Hogan, B. L. (1996). The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes and Development, 10(13), 1657-1669.
15. Brown, S., Zeidler, M. P., & Hombría, J. E. (2006). JAK/STAT signalling in Drosophila controls cell motility during germ cell migration. Developmental Dynamics, 235(4), 958-966.
16. Matsuda, T., Nakamura, T., Nakao, K., Arai, T., Katsuki, M., Heike, T., et al. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO Journal, 18(15), 4261-4269.
17. Gat, U., DasGupta, R., Degenstein, L., & Fuchs, E. (1998). De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell, 95(5), 605-614.
18. Song, X., & Xie, T. (2003). Wingless signaling regulates the maintenance of ovarian somatic stem cells in Drosophila. Development, 130(14), 3259-3268.
19. van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., et al. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111(2), 241-250.
20. Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., et al. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423(6938), 409-414.
21. Virchow, R. L. K. (1858). Cellular Pathology. A. Hirschwald (Ed.). Berlin.
22. Sell, S. (2004). Stem cell origin of cancer and differentiation therapy. Critical Reviews in Oncology/hematology, 51(1), 1-28.
23. Garraway, L. A., & Sellers, W. R. (2006). Lineage dependency and lineage-survival oncogenes in human cancer. Nature Reviews Cancer, 6(8), 593-602.
24. Yang, Z. J., & Wechsler-Reya, R. J. (2007). Hit 'em where they live: targeting the cancer stem cell niche. Cancer Cell, 11(1), 3-5.
25. Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., et al. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367(6464), 645-648.
26. Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H., Jones, D. L., et al. (2006). Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research, 66(19), 9339-9344.
27. Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 1(5), 555-567.
28. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3(7), 730-737.
29. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63(18), 5821-5828.
30. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences USA, 100(7), 3983-3988.
31. O'Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445(7123), 106-110.
32. Zhang, S., Balch, C., Chan, M. W., Lai, H. C., Matei, D., Schilder, J. M., et al. (2008). Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Research, 68(11), 4311-4320.
33. Guo, W., Lasky, J. L., Chang, C. J., Mosessian, S., Lewis, X., Xiao, Y., et al. (2008). Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature, 453(7194), 529-533.
34. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature, 432(7015), 396-401.
35. Cho, R. W., & Clarke, M. F. (2008). Recent advances in cancer stem cells. Current Opinion in Genetics and Development, 18(1), 48-53.
36. Zhang, M., Behbod, F., Atkinson, R. L., Landis, M. D., Kittrell, F., Edwards, D., et al. (2008). Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Research, 68(12), 4674-4682.
37. Huntly, B. J., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., et al. (2004). MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell, 6(6), 587-596.
38. Postovit, L. M., Seftor, E. A., Seftor, R. E., & Hendrix, M. J. (2006). Influence of the microenvironment on melanoma cell fate determination and phenotype. Cancer Research, 66(16), 7833-7836.
39. Bissell, M. J., & Radisky, D. (2001). Putting tumours in context. Nature Reviews Cancer, 1(1), 46-54.
40. Gupta, G. P., & Massagué, J. (2006). Cancer metastasis: building a framework. Cell, 127(4), 679-695.
41. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57-70.
42. Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer, 2(8), 563-572.
43. Huang, J., Frischer, J. S., Serur, A., Kadenhe, A., Yokoi, A., McCrudden, K. W., et al. (2003). Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proceedings of the National Academy of Sciences USA, 100(13), 7785-7790.
44. Pardal, R., Clarke, M. F., & Morrison, S. J. (2003). Applying the principles of stem-cell biology to cancer. Nature Reviews Cancer, 3(12), 895-902.
45. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3(7), 730-737.
46. Lessard, J., & Sauvageau, G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature, 423(6937), 255-260.
47. Bissell, M. J., & Labarge, M. A. (2005). Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell, 7(1), 17-23.
48. Mantovani, A. (2005). Cancer: inflammation by remote control. Nature, 435(7043), 752-753.
49. Rosen, J. M., & Jordan, C. T. (2009). The increasing complexity of the cancer stem cell paradigm. Science, 324(5935), 1670-1673.
50. Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell, 11(1), 69-82.
51. Tlsty, T. D., & Coussens, L. M. (2006). Tumor stroma and regulation of cancer development. Annual Review of Pathol, 1, 119-150.
52. Walkley, C. R., Olsen, G. H., Dworkin, S., Fabb, S. A., Swann, J., McArthur, G. A., et al. (2007). A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell, 129(6), 1097-1110.
53. Walkley, C. R., Shea, J. M., Sims, N. A., Purton, L. E., & Orkin, S. H. (2007). Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell, 129(6), 1081-1095.
54. Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., Hjelmeland, A. B., et al. (2006). Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Research, 66(16), 7843-7848.
55. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820-827.
56. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145-1147.
57. Draper, J. S., Moore, H. D., Ruban, L. N., Gokhale, P. J., & Andrews, P. W. (2004). Culture and characterization of human embryonic stem cells. Stem Cells and Development, 13(4), 325-336.
58. Rao, M. (2004). Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. Developmental Biology, 275(2), 269-286.
59. Surani, M. A., Hayashi, K., & Hajkova, P. (2007). Genetic and epigenetic regulators of pluripotency. Cell, 128(4), 747-762.
60. Calvanese, V., Horrillo, A., Hmadcha, A., Suarez-Alvarez, B., Fernandez, A. F., Lara, E., et al. (2008). Cancer genes hypermethylated in human embryonic stem cells. PLoS ONE, 3(9), e3294.
61. Jaenisch, R., & Young, R. (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell, 132(4), 567-582.
62. Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., et al. (2004). Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nature Biotechnology, 22(1), 53-54.
63. Vanneste, E., Voet, T., Le Caignec, C., Ampe, M., Konings, P., Melotte, C., et al. (2009). Chromosome instability is common in human cleavage-stage embryos. Nature Medicine, 15(5), 577-583.
64. Pierce, G. B., Pantazis, C. G., Caldwell, J. E., & Wells, R. S. (1982). Specificity of the control of tumor formation by the blastocyst. Cancer Research, 42(3), 1082-1087.
65. Cucina, A., Biava, P. M., D'Anselmi, F., Coluccia, P., Conti, F., di Clemente, R., et al. (2006). Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2). Apoptosis, 11(9), 1617-1628.
66. Postovit, L. M., Margaryan, N. V., Seftor, E. A., Kirschmann, D. A., Lipavsky, A., Wheaton, W. W., et al. (2008). Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proceedings of the National Academy of Sciences USA, 105(11), 4329-4334.
67. Topczewska, J. M., Postovit, L. M., Margaryan, N. V., Sam, A., Hess, A. R., Wheaton, W. W., et al. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature Medicine, 12(8), 925-932.
68. Dürr, M., Harder, F., Merkel, A., Bug, G., Henschler, R., & Müller, A. M. (2003). Chimaerism and erythroid marker expression after microinjection of human acute myeloid leukaemia cells into murine blastocysts. Oncogene, 22(57), 9185-9191.
69. Mintz, B., & Illmensee, K. (1975). Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proceedings of the National Academy of Sciences USA, 72(9), 3585-3589.
70. Gerschenson, M., Graves, K., Carson, S. D., Wells, R. S., & Pierce, G. B. (1986). Regulation of melanoma by the embryonic skin. Proceedings of the National Academy of Sciences USA, 83(19), 7307-7310.
71. Dolberg, D. S., & Bissell, M. J. (1984). Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature, 309(5968), 552-556.
72. Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448(7151), 313-317.
73. Hendrix, M. J., Seftor, E. A., Seftor, R. E., Kasemeier-Kulesa, J., Kulesa, P. M., & Postovit, L. M. (2007). Reprogramming metastatic tumour cells with embryonic microenvironments. Nature Reviews Cancer, 7(4), 246-255.